Khiron Life Sciences Corp.
KHRNF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.3M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $9.30 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.2 |
| Beta | 5.43 |
| Outstanding Shares | 214,528,399 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.2 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$2.15 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$2.15 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Khiron Life Sciences Corp.
310 employees
CEO: Alvaro Francisco Torres
Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe. The company's business is structured into three primary segments: Health Services, Medical ...